Literature DB >> 22878353

Plasma N-terminal pro-brain natriuretic peptide levels identifying left ventricular diastolic dysfunction in patients with preserved ejection fraction.

Hiroo Sonoda1, Nobuyuki Ohte, Toshihiko Goto, Kazuaki Wakami, Hidekatsu Fukuta, Shohei Kikuchi, Tomomitsu Tani, Genjiro Kimura.   

Abstract

BACKGROUND: Diagnosis of left ventricular (LV) diastolic dysfunction by blood testing is expedient in the clinical setting. METHODS AND
RESULTS: In 98 patients with LV ejection fraction ≥50% who underwent cardiac catheterization for evaluation of coronary artery disease, LV pressure (LVP) was measured using a catheter-tipped micromanometer. A time constant, τ, of LV relaxation was computed from LVP decay; the inertia force (IF) of late systolic aortic flow, a surrogate index of LV elastic recoil, was also computed from the LVP-dP/dt relation (phase loop). Patients were classified into 2 groups: those with impaired LV relaxation (τ ≥48 ms) and those with preserved LV relaxation (τ <48 ms). Patients were also classified into another 2 groups: those with IF (≥0.5 mmHg) and those without (<0.5 mmHg). Plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) ≥56.5 pg/ml had a sensitivity of 100%, specificity of 52.5%, and negative predictive value of 100% for identifying impaired LV relaxation. NT-proBNP ≥244.5 pg/ml had a sensitivity of 62.5% and specificity of 93.9% for detecting lack of IF.
CONCLUSIONS: NT-proBNP level <56.5 pg/ml could be used as a value to sensitively identify patients with preserved LV systolic and diastolic function among those with coronary artery disease. NT-proBNP level ≥244.5 pg/ml is able to specifically detect a lack of IF and has potential for specifically diagnosing LV isolated diastolic dysfunction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22878353     DOI: 10.1253/circj.cj-12-0406

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  4 in total

1.  Relation of N-terminal pro-B-type natriuretic peptide with diastolic function in hypertensive heart disease.

Authors:  Imran Uraizee; Susan Cheng; Chung-Lieh Hung; Anil Verma; James D Thomas; Michael R Zile; Gerard P Aurigemma; Scott D Solomon
Journal:  Am J Hypertens       Date:  2013-06-22       Impact factor: 2.689

2.  Assessment of BNP and BDNF results in elective endovascular cerebral aneurysm treatment.

Authors:  Abdullah Sukun; Bulent Cekic
Journal:  Ir J Med Sci       Date:  2021-09-29       Impact factor: 2.089

3.  N-terminal Pro-brain Natriuretic Peptide Level as a Prognostic Predictor in Elderly Patients in a Convalescent Rehabilitation Ward.

Authors:  Atsushi Shiba; Hiromitsu Kurata; Hirokazu Sasaki; Mitsugu Naoe; Kazufumi Kunitomo; Atsuko Yamakami
Journal:  Prog Rehabil Med       Date:  2017-12-28

4.  Associations of tissue Doppler imaging with NT-proBNP and hs-TnT: a pilot study in end-stage renal disease.

Authors:  Ruth F Dubin; Alexis L Beatty; John R Teerlink; Nelson B Schiller; Dean Alokozai; Kirsten L Johansen
Journal:  Echocardiography       Date:  2014-11       Impact factor: 1.724

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.